• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳武利尤单抗致胃癌患者急性粒细胞性间质性肾炎

Nivolumab-induced acute granulomatous tubulointerstitial nephritis in a patient with gastric cancer.

机构信息

Department of Nephrology, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka, 589-8511, Japan.

Department of Clinical Oncology, Kindai University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-sayama, Osaka, 589-8511, Japan.

出版信息

Invest New Drugs. 2018 Aug;36(4):726-731. doi: 10.1007/s10637-018-0596-7. Epub 2018 Apr 6.

DOI:10.1007/s10637-018-0596-7
PMID:29623482
Abstract

We here report a case of nivolumab-induced acute granulomatous tubulointerstitial nephritis in a patient with gastric cancer. A 68-year-old woman with recurrent gastric cancer developed acute kidney injury associated with kidney enlargement and urinary leukocytes after 38 cycles of nivolumab treatment. A diagnosis of acute granulomatous tubulointerstitial nephritis was made based on kidney biopsy findings. Immunohistochemistry revealed expression of programmed cell death-ligand 1 (PD-L1) in degenerated epithelial cells of collecting tubules. Among infiltrating immune cells, aggregation of T cells was more extensive than that of B cells, with CD4 T cells outnumbering CD8 T cells, consistent with the relative numbers of these cells in the circulation. Treatment with methylprednisolone (1.0 mg/kg daily) led to a rapid improvement in renal function and reduction in the number of circulating CD4 T cells. Prompt administration of high-dose corticosteroid is thus recommended after diagnosis of this adverse event of nivolumab treatment by kidney biopsy.

摘要

我们在此报告一例纳武利尤单抗引起的胃癌患者急性粒细胞性间质性肾炎。一名 68 岁女性因复发性胃癌,在接受 38 个周期纳武利尤单抗治疗后,出现急性肾损伤、肾脏增大和尿白细胞。根据肾活检结果诊断为急性粒细胞性间质性肾炎。免疫组化显示在集合管的变性上皮细胞中表达程序性死亡配体 1(PD-L1)。在浸润的免疫细胞中,T 细胞聚集比 B 细胞更广泛,CD4 T 细胞多于 CD8 T 细胞,与这些细胞在循环中的相对数量一致。每日 1.0mg/kg 甲泼尼龙治疗导致肾功能迅速改善,循环 CD4 T 细胞数量减少。因此,建议在通过肾活检诊断出纳武利尤单抗治疗的这种不良事件后,立即给予大剂量皮质类固醇治疗。

相似文献

1
Nivolumab-induced acute granulomatous tubulointerstitial nephritis in a patient with gastric cancer.纳武利尤单抗致胃癌患者急性粒细胞性间质性肾炎
Invest New Drugs. 2018 Aug;36(4):726-731. doi: 10.1007/s10637-018-0596-7. Epub 2018 Apr 6.
2
Immune checkpoint inhibitor (nivolumab)-associated kidney injury and the importance of recognizing concomitant medications known to cause acute tubulointerstitial nephritis: a case report.免疫检查点抑制剂(纳武利尤单抗)相关肾损伤以及识别已知可引起急性肾小管间质性肾炎的伴随用药的重要性:一例报告
BMC Nephrol. 2018 Feb 27;19(1):48. doi: 10.1186/s12882-018-0848-y.
3
The Analysis of Renal Infiltrating Cells in Acute Tubulointerstitial Nephritis Induced by Anti-PD-1 Antibodies: A Case Report and Review of the Literature.抗程序性死亡蛋白1(PD-1)抗体诱导的急性肾小管间质性肾炎肾浸润细胞分析:一例报告并文献复习
Intern Med. 2018 Nov 1;57(21):3135-3139. doi: 10.2169/internalmedicine.0444-17. Epub 2018 Jun 6.
4
Immune checkpoint inhibitors associated granulomatous small vessel vasculitis accompanied with tubulointerstitial nephritis: a case report.免疫检查点抑制剂相关肉芽肿性小血管血管炎伴肾小管间质性肾炎:病例报告。
BMC Nephrol. 2023 Mar 9;24(1):48. doi: 10.1186/s12882-023-03091-8.
5
Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma.转移性黑色素瘤序贯伊匹单抗-纳武单抗治疗后发生急性间质性肾炎。
J Immunother Cancer. 2017 Jul 18;5(1):57. doi: 10.1186/s40425-017-0261-2.
6
[A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma].[一例转移性肾细胞癌患者发生的迟发性纳武单抗诱导的间质性肾炎病例]
Hinyokika Kiyo. 2019 May;65(5):157-161. doi: 10.14989/ActaUrolJap_65_5_157.
7
Interstitial nephritis associated with nivolumab in a patient with hodgkin lymphoma.一名霍奇金淋巴瘤患者中与纳武单抗相关的间质性肾炎。
Rev Assoc Med Bras (1992). 2019 Aug 5;65(7):934-936. doi: 10.1590/1806-9282.65.7.934.
8
Acute tubulointerstitial nephritis and IgM deposits on glomerular capillary walls after immunotherapy with nivolumab for metastatic renal cell carcinoma.纳武利尤单抗免疫治疗转移性肾细胞癌后出现急性肾小管间质性肾炎和 IgM 在肾小球毛细血管壁沉积。
CEN Case Rep. 2020 Feb;9(1):48-54. doi: 10.1007/s13730-019-00424-1. Epub 2019 Oct 11.
9
Nivolumab-induced IgA nephropathy in a patient with advanced gastric cancer: A case report.纳武利尤单抗诱发晚期胃癌患者IgA肾病:一例报告
Medicine (Baltimore). 2020 May 22;99(21):e20464. doi: 10.1097/MD.0000000000020464.
10
[Severe interstitial lung disease after one cycle of nivolumab treatment in a patient with advanced gastric cancer].[一名晚期胃癌患者接受纳武利尤单抗治疗一个周期后出现严重间质性肺病]
Nihon Shokakibyo Gakkai Zasshi. 2019;116(2):153-160. doi: 10.11405/nisshoshi.116.153.

引用本文的文献

1
Biopsy-proven acute tubulointerstitial nephritis in patients treated with immune checkpoint inhibitors: a pooled analysis of case reports.经活检证实的接受免疫检查点抑制剂治疗患者的急性肾小管间质性肾炎:病例报告的汇总分析
Front Oncol. 2023 Oct 23;13:1221135. doi: 10.3389/fonc.2023.1221135. eCollection 2023.
2
PD-1/PD-L1 axis in organ fibrosis.PD-1/PD-L1 轴在器官纤维化中的作用。
Front Immunol. 2023 May 19;14:1145682. doi: 10.3389/fimmu.2023.1145682. eCollection 2023.
3
Renal Sarcoidosis-like Reaction Induced by PD-1 Inhibitor Treatment in Non-Small Cell Lung Cancer: A Case Report and Literature Review.

本文引用的文献

1
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial.纳武利尤单抗治疗既往至少两种化疗方案治疗失败或不耐受的晚期胃或胃食管结合部腺癌患者(ONO-4538-12,ATTRACTION-2):一项随机、双盲、安慰剂对照、III 期临床试验。
Lancet. 2017 Dec 2;390(10111):2461-2471. doi: 10.1016/S0140-6736(17)31827-5. Epub 2017 Oct 6.
2
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small-Cell Lung Cancer.免疫相关不良反应与纳武利尤单抗治疗非小细胞肺癌疗效的相关性。
JAMA Oncol. 2018 Mar 1;4(3):374-378. doi: 10.1001/jamaoncol.2017.2925.
3
PD-1 抑制剂治疗非小细胞肺癌致类肉瘤样反应 1 例报告并文献复习
Medicina (Kaunas). 2023 May 21;59(5):991. doi: 10.3390/medicina59050991.
4
Clinicopathological Features of Kidney Injury Related to Immune Checkpoint Inhibitors: A Systematic Review.免疫检查点抑制剂相关肾损伤的临床病理特征:一项系统评价
J Clin Med. 2023 Feb 8;12(4):1349. doi: 10.3390/jcm12041349.
5
Management of acute kidney injury in gastrointestinal tumor: An overview.胃肠道肿瘤急性肾损伤的管理:综述
World J Clin Cases. 2021 Dec 16;9(35):10746-10764. doi: 10.12998/wjcc.v9.i35.10746.
6
PD-1 immunobiology in glomerulonephritis and renal cell carcinoma.PD-1 免疫生物学在肾小球肾炎和肾细胞癌中的作用。
BMC Nephrol. 2021 Mar 6;22(1):80. doi: 10.1186/s12882-021-02257-6.
7
Acute Kidney Injury in Oncology Patients.肿瘤患者的急性肾损伤
J Cancer. 2020 May 22;11(16):4700-4708. doi: 10.7150/jca.45382. eCollection 2020.
8
Reintroduction of nivolumab in a patient with gastric cancer after improvement of nivolumab-induced acute interstitial nephritis: a case report.纳武利尤单抗诱导的急性间质性肾炎改善后,一名胃癌患者重新使用纳武利尤单抗:病例报告
Int Cancer Conf J. 2020 May 22;9(3):127-132. doi: 10.1007/s13691-020-00418-2. eCollection 2020 Jul.
9
Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations.接受PD-1/PD-L1阻断治疗的癌症患者不良事件的管理:聚焦亚洲人群。
Front Pharmacol. 2019 Jul 2;10:726. doi: 10.3389/fphar.2019.00726. eCollection 2019.
10
Antitumor evaluation of novel phenothiazine derivatives that inhibit migration and tubulin polymerization against gastric cancer MGC-803 cells.新型吩噻嗪衍生物抑制胃癌 MGC-803 细胞迁移和微管聚合的抗肿瘤评价。
Invest New Drugs. 2019 Feb;37(1):188-198. doi: 10.1007/s10637-018-0682-x. Epub 2018 Oct 22.
Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitor.
黑色素瘤患者接受 PD-1 检查点抑制剂治疗后发生间质性肾炎。
J Immunother Cancer. 2017 Jan 17;5:3. doi: 10.1186/s40425-016-0205-2. eCollection 2017.
4
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review.免疫检查点抑制剂的肾脏不良反应:一项叙述性综述
Am J Nephrol. 2017;45(2):160-169. doi: 10.1159/000455014. Epub 2017 Jan 12.
5
Renal effects of immune checkpoint inhibitors.免疫检查点抑制剂的肾脏作用。
Nephrol Dial Transplant. 2017 Jun 1;32(6):936-942. doi: 10.1093/ndt/gfw382.
6
Acute interstitial nephritis related to immune checkpoint inhibitors.与免疫检查点抑制剂相关的急性间质性肾炎。
Br J Cancer. 2016 Dec 6;115(12):1457-1461. doi: 10.1038/bjc.2016.358. Epub 2016 Nov 10.
7
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.纳武利尤单抗对比多西他赛治疗晚期非鳞状非小细胞肺癌
N Engl J Med. 2015 Oct 22;373(17):1627-39. doi: 10.1056/NEJMoa1507643. Epub 2015 Sep 27.
8
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.纳武单抗与依维莫司治疗晚期肾细胞癌的比较
N Engl J Med. 2015 Nov 5;373(19):1803-13. doi: 10.1056/NEJMoa1510665. Epub 2015 Sep 25.
9
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.抗程序性死亡-1 单药(MDX-1106)治疗难治性实体瘤的 I 期研究:安全性、临床活性、药效学和免疫相关性。
J Clin Oncol. 2010 Jul 1;28(19):3167-75. doi: 10.1200/JCO.2009.26.7609. Epub 2010 Jun 1.
10
Expression of B7-H1 in inflammatory renal tubular epithelial cells.B7-H1在炎性肾小管上皮细胞中的表达。
Nephron Exp Nephrol. 2006;102(3-4):e81-92. doi: 10.1159/000089686. Epub 2005 Nov 11.